Advancing gene editing techniques using nonhuman primates
Center for Somatic Cell Genome Editing in Nonhuman Primates
This study is working on improving gene editing techniques to help treat diseases in people, using nonhuman primates to test new ideas, and it aims to bring researchers together to find better treatments that could eventually be used in human trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-10911364 on NIH RePORTER |
What this research studies
This research focuses on enhancing somatic cell genome editing technologies to treat human diseases by utilizing nonhuman primate models. The project aims to create a collaborative environment for researchers to conduct high-quality studies that can lead to breakthroughs in gene therapy. By leveraging the resources and expertise at UC Davis, the center will support various studies that target a wide range of diseases, ultimately aiming to translate these findings into human clinical trials. The research will also foster partnerships to accelerate the development of innovative treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic disorders or diseases that could potentially benefit from advanced gene editing therapies.
Not a fit: Patients with conditions that are not amenable to gene editing or those outside the age range of 21+ years may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new gene therapies that effectively treat a variety of human diseases.
How similar studies have performed: Previous research in somatic cell genome editing has shown promising results, indicating that this approach has the potential for significant advancements in treatment.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Tarantal, Alice F — University of California at Davis
- Study coordinator: Tarantal, Alice F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.